Prolonged administration of temozolomide in adult patients with anaplastic glioma
Purpose: Prolonged administration of temozolomide is widely used in patients with glioblastoma; whereas the treatment of anaplastic glioma differs between neurooncological centres. The safety, feasibility and efficacy of prolonged temozolomide administration in patients with anaplastic gliomas was e...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
November 21, 2011
|
| In: |
Anticancer research
Year: 2011, Jahrgang: 31, Heft: 11, Pages: 3873-3877 |
| ISSN: | 1791-7530 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://ar.iiarjournals.org/content/31/11/3873
|
| Verfasserangaben: | C.F. Freyschlag, D.R. Smolczyk, E. Janzen, K. Schmieder, C. Thomé, F. Lohr, F. Wenz, C. Weiss, J. Tuettenberg and M. Seiz |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1844975940 | ||
| 003 | DE-627 | ||
| 005 | 20250908115232.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230510s2011 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1844975940 | ||
| 035 | |a (DE-599)KXP1844975940 | ||
| 035 | |a (OCoLC)1389736778 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Freyschlag, Christian F. |e VerfasserIn |0 (DE-588)115863286X |0 (DE-627)1020619996 |0 (DE-576)504264214 |4 aut | |
| 245 | 1 | 0 | |a Prolonged administration of temozolomide in adult patients with anaplastic glioma |c C.F. Freyschlag, D.R. Smolczyk, E. Janzen, K. Schmieder, C. Thomé, F. Lohr, F. Wenz, C. Weiss, J. Tuettenberg and M. Seiz |
| 264 | 1 | |c November 21, 2011 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.05.2023 | ||
| 500 | |a Kein DOI vorhanden | ||
| 520 | |a Purpose: Prolonged administration of temozolomide is widely used in patients with glioblastoma; whereas the treatment of anaplastic glioma differs between neurooncological centres. The safety, feasibility and efficacy of prolonged temozolomide administration in patients with anaplastic gliomas was evaluated. Patients and Methods: Forty-two patients with primary, recurrent or secondary anaplastic glioma were retrospectively analysed for the course of their disease. Treatment mostly consisted of surgery, followed by radiotherapy with concomitant and adjuvant temozolomide. In five patients with recurrence of primary anaplastic glioma, chemotherapy was initiated without previous surgery. Temozolomide was administered until evidence of tumour recurrence, appearance of serious side-effects or patients’ wish to finish chemotherapy. Results: The median overall survival (OS) was 39 months with a median cycle number of 7.5 (1-42). Treatment with temozolomide was stopped in 12 patients due to side-effects in general, whereas in only three patients (7.1%) treatment had to be discontinued due to haematological side-effects. There was no evidence of treatment related infections or grade IV toxicity. Extent of surgery had a significant influence on OS in anaplastic gliomas, the number of adjuvant temozolomide cycles showed a positive influence as well on time to progression (TTP) and OS. Conclusion: Prolonged administration of adjuvant temozolomide is safe and can be favorable for patients with anaplastic gliomas. | ||
| 650 | 4 | |a Anaplastic gliomas | |
| 650 | 4 | |a long-term administration | |
| 650 | 4 | |a temozolomide | |
| 700 | 1 | |a Smolczyk, Dahlia-Rosa |d 1983- |e VerfasserIn |0 (DE-588)1058142755 |0 (DE-627)796443491 |0 (DE-576)414140346 |4 aut | |
| 700 | 1 | |a Janzen, E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmieder, Kirsten |d 1961- |e VerfasserIn |0 (DE-588)104189953X |0 (DE-627)767916034 |0 (DE-576)39356469X |4 aut | |
| 700 | 1 | |a Thomé, Claudius |d 1969- |e VerfasserIn |0 (DE-588)115708847 |0 (DE-627)691529078 |0 (DE-576)290032156 |4 aut | |
| 700 | 1 | |a Lohr, Frank |e VerfasserIn |0 (DE-588)1025307194 |0 (DE-627)72201967X |0 (DE-576)37018694X |4 aut | |
| 700 | 1 | |a Wenz, Frederik |d 1966- |e VerfasserIn |0 (DE-588)113310390 |0 (DE-627)663837766 |0 (DE-576)346656281 |4 aut | |
| 700 | 1 | |a Weiß, Christel |d 1958- |e VerfasserIn |0 (DE-588)123287707 |0 (DE-627)082463417 |0 (DE-576)168356104 |4 aut | |
| 700 | 1 | |a Tüttenberg, Jochen |d 1970- |e VerfasserIn |0 (DE-588)12164362X |0 (DE-627)081440790 |0 (DE-576)292812744 |4 aut | |
| 700 | 1 | |a Seiz-Rosenhagen, Marcel |d 1977- |e VerfasserIn |0 (DE-588)129921807 |0 (DE-627)483655503 |0 (DE-576)297904019 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anticancer research |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004 |g 31(2011), 11 vom: Nov., Seite 3873-3877 |h Online-Ressource |w (DE-627)387478493 |w (DE-600)2145376-7 |w (DE-576)358408717 |x 1791-7530 |7 nnas |a Prolonged administration of temozolomide in adult patients with anaplastic glioma |
| 773 | 1 | 8 | |g volume:31 |g year:2011 |g number:11 |g month:11 |g pages:3873-3877 |g extent:5 |a Prolonged administration of temozolomide in adult patients with anaplastic glioma |
| 856 | 4 | 0 | |u https://ar.iiarjournals.org/content/31/11/3873 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230510 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 129921807 |a Seiz-Rosenhagen, Marcel |m 129921807:Seiz-Rosenhagen, Marcel |d 60000 |e 60000PS129921807 |k 0/60000/ |p 10 |y j | ||
| 998 | |g 12164362X |a Tüttenberg, Jochen |m 12164362X:Tüttenberg, Jochen |d 60000 |e 60000PT12164362X |k 0/60000/ |p 9 | ||
| 998 | |g 123287707 |a Weiß, Christel |m 123287707:Weiß, Christel |d 60000 |d 60200 |d 60250 |e 60000PW123287707 |e 60200PW123287707 |e 60250PW123287707 |k 0/60000/ |k 1/60000/60200/ |k 2/60000/60200/60250/ |p 8 | ||
| 998 | |g 113310390 |a Wenz, Frederik |m 113310390:Wenz, Frederik |d 60000 |d 63000 |e 60000PW113310390 |e 63000PW113310390 |k 0/60000/ |k 1/60000/63000/ |p 7 | ||
| 998 | |g 1025307194 |a Lohr, Frank |m 1025307194:Lohr, Frank |d 60000 |d 63000 |e 60000PL1025307194 |e 63000PL1025307194 |k 0/60000/ |k 1/60000/63000/ |p 6 | ||
| 998 | |g 115708847 |a Thomé, Claudius |m 115708847:Thomé, Claudius |p 5 | ||
| 998 | |g 104189953X |a Schmieder, Kirsten |m 104189953X:Schmieder, Kirsten |d 60000 |d 62600 |e 60000PS104189953X |e 62600PS104189953X |k 0/60000/ |k 1/60000/62600/ |p 4 | ||
| 998 | |g 1058142755 |a Smolczyk, Dahlia-Rosa |m 1058142755:Smolczyk, Dahlia-Rosa |d 60000 |d 62600 |e 60000PS1058142755 |e 62600PS1058142755 |k 0/60000/ |k 1/60000/62600/ |p 2 | ||
| 998 | |g 115863286X |a Freyschlag, Christian F. |m 115863286X:Freyschlag, Christian F. |p 1 |x j | ||
| 999 | |a KXP-PPN1844975940 |e 4320320948 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"note":["Gesehen am 26.02.13"],"origin":[{"dateIssuedDisp":"2004-","publisher":"International Institute of Anticancer Research","publisherPlace":"Kapandriti, Attiki, Greece","dateIssuedKey":"2004"}],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["International Institute of Anticancer Research"]},"recId":"387478493","id":{"zdb":["2145376-7"],"eki":["387478493"],"issn":["1791-7530"]},"pubHistory":["Nachgewiesen 24.2004 -"],"title":[{"title_sort":"Anticancer research","title":"Anticancer research","subtitle":"international journal of cancer research and treatment"}],"part":{"volume":"31","year":"2011","extent":"5","text":"31(2011), 11 vom: Nov., Seite 3873-3877","pages":"3873-3877","issue":"11"},"disp":"Prolonged administration of temozolomide in adult patients with anaplastic gliomaAnticancer research","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"person":[{"display":"Freyschlag, Christian F.","role":"aut","given":"Christian F.","family":"Freyschlag"},{"family":"Smolczyk","given":"Dahlia-Rosa","role":"aut","display":"Smolczyk, Dahlia-Rosa"},{"display":"Janzen, E.","role":"aut","given":"E.","family":"Janzen"},{"given":"Kirsten","family":"Schmieder","display":"Schmieder, Kirsten","role":"aut"},{"display":"Thomé, Claudius","role":"aut","given":"Claudius","family":"Thomé"},{"given":"Frank","family":"Lohr","role":"aut","display":"Lohr, Frank"},{"given":"Frederik","family":"Wenz","display":"Wenz, Frederik","role":"aut"},{"role":"aut","display":"Weiß, Christel","family":"Weiß","given":"Christel"},{"family":"Tüttenberg","given":"Jochen","role":"aut","display":"Tüttenberg, Jochen"},{"display":"Seiz-Rosenhagen, Marcel","role":"aut","given":"Marcel","family":"Seiz-Rosenhagen"}],"title":[{"title":"Prolonged administration of temozolomide in adult patients with anaplastic glioma","title_sort":"Prolonged administration of temozolomide in adult patients with anaplastic glioma"}],"physDesc":[{"extent":"5 S."}],"note":["Gesehen am 10.05.2023","Kein DOI vorhanden"],"origin":[{"dateIssuedDisp":"November 21, 2011","dateIssuedKey":"2011"}],"id":{"eki":["1844975940"]},"recId":"1844975940","name":{"displayForm":["C.F. Freyschlag, D.R. Smolczyk, E. Janzen, K. Schmieder, C. Thomé, F. Lohr, F. Wenz, C. Weiss, J. Tuettenberg and M. Seiz"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a FREYSCHLAGPROLONGEDA2120 | ||